Your browser is no longer supported. Please, upgrade your browser.
MRK [NYSE]
Merck & Co., Inc.
IndexDJIA S&P500 P/E18.34 EPS (ttm)4.55 Insider Own0.08% Shs Outstand2.53B Perf Week0.42%
Market Cap213.47B Forward P/E13.05 EPS next Y6.39 Insider Trans-23.24% Shs Float2.53B Perf Month3.60%
Income11.57B PEG2.45 EPS next Q1.38 Inst Own76.00% Short Float0.54% Perf Quarter5.46%
Sales47.35B P/S4.51 EPS this Y58.90% Inst Trans0.02% Short Ratio1.52 Perf Half Y4.39%
Book/sh11.54 P/B7.23 EPS next Y6.82% ROA13.20% Target Price96.53 Perf Year-8.55%
Cash/sh2.87 P/C29.02 EPS next 5Y7.48% ROE42.30% 52W Range65.25 - 92.06 Perf YTD1.93%
Dividend2.60 P/FCF325.41 EPS past 5Y-1.10% ROI19.20% 52W High-9.42% Beta0.43
Dividend %3.12% Quick Ratio1.00 Sales past 5Y2.10% Gross Margin73.20% 52W Low27.79% ATR1.63
Employees71000 Current Ratio1.30 Sales Q/Q1.20% Oper. Margin26.90% RSI (14)57.03 Volatility2.17% 1.90%
OptionableYes Debt/Eq0.98 EPS Q/Q56.80% Profit Margin24.30% Rel Volume1.08 Prev Close82.17
ShortableYes LT Debt/Eq0.90 EarningsFeb 04 BMO Payout53.70% Avg Volume8.92M Price83.38
Recom2.00 SMA202.55% SMA502.83% SMA2003.59% Volume9,632,355 Change1.47%
Nov-10-20Resumed Bernstein Outperform $95
Sep-29-20Initiated Berenberg Hold $88
Aug-03-20Upgrade Goldman Neutral → Buy $91 → $105
Jun-12-20Downgrade Wolfe Research Outperform → Peer Perform
Feb-27-20Initiated Barclays Overweight $93
Jan-07-20Initiated RBC Capital Mkts Sector Perform $99
Oct-17-19Resumed BofA/Merrill Neutral $90
Aug-16-19Initiated SVB Leerink Outperform
Jul-03-19Initiated Mizuho Buy $97
May-28-19Initiated Goldman Neutral
May-13-19Upgrade Atlantic Equities Neutral → Overweight
Oct-16-18Reiterated Citigroup Buy $70 → $79
Oct-09-18Resumed Guggenheim Buy
Apr-23-18Upgrade Goldman Neutral → Buy
Apr-17-18Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-05-18Upgrade Barclays Equal Weight → Overweight $62 → $64
Mar-12-18Upgrade Leerink Partners Mkt Perform → Outperform
Feb-14-18Reiterated Leerink Partners Mkt Perform $67 → $66
Feb-07-18Reiterated Morgan Stanley Equal-Weight $60 → $63
Jan-16-18Upgrade SunTrust Hold → Buy
Jan-15-21 08:14AM  
Jan-14-21 05:45PM  
04:35PM  
Jan-13-21 10:08AM  
Jan-12-21 04:56PM  
09:12AM  
08:15AM  
06:45AM  
Jan-11-21 08:40AM  
08:25AM  
Jan-09-21 12:37PM  
Jan-08-21 05:50PM  
04:12PM  
10:18AM  
06:45AM  
04:23AM  
Jan-07-21 08:51AM  
Jan-05-21 10:57AM  
10:23AM  
07:40AM  
Jan-04-21 06:45AM  
Jan-01-21 10:32AM  
04:00AM  
Dec-31-20 05:11PM  
10:25AM  
10:20AM  
Dec-30-20 12:04PM  
Dec-29-20 10:10AM  
06:01AM  
Dec-28-20 09:08PM  
06:45AM  
Dec-24-20 09:08AM  
06:08AM  
Dec-23-20 04:00PM  
02:06PM  
02:03PM  
01:53PM  
12:17PM  
11:15AM  
10:20AM  
09:39AM  
08:57AM  
08:56AM  
08:29AM  
07:32AM  
07:20AM  
06:45AM  
Dec-22-20 05:50PM  
09:08AM  
Dec-19-20 05:57PM  
Dec-18-20 04:25PM  
01:55PM  
10:25AM  
07:34AM  
Dec-17-20 06:45AM  
Dec-16-20 05:50PM  
06:45AM  
Dec-15-20 10:02AM  
Dec-14-20 10:15AM  
09:36AM  
Dec-13-20 01:03PM  
Dec-11-20 07:10AM  
Dec-10-20 05:45PM  
Dec-09-20 08:29AM  
12:20AM  
Dec-08-20 10:32AM  
Dec-06-20 04:19PM  
Dec-05-20 08:45AM  
Dec-04-20 08:49AM  
Dec-03-20 12:24PM  
06:05AM  
Dec-02-20 04:24PM  
11:12AM  
10:17AM  
10:14AM  
09:17AM  
09:04AM  
07:33AM  
Nov-30-20 10:43AM  
06:45AM  
05:37AM  
Nov-27-20 05:44PM  
08:52AM  
Nov-26-20 06:55AM  
Nov-25-20 08:00AM  
Nov-24-20 05:25PM  
03:22PM  
10:14AM  
09:45AM  
08:58AM  
07:19AM  
01:49AM  
Nov-23-20 03:15PM  
02:01PM  
11:19AM  
11:12AM  
09:58AM  
09:46AM  
09:06AM  
06:47AM  
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; FUJIFILM Corporation; Intec Pharma Ltd.; Transcenta Holding Ltd.; and Janux Therapeutics, Inc. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FRAZIER KENNETH CChairman, President & CEONov 09Sale81.42280,00022,797,011411,546Nov 12 04:45 PM
Nally MichaelEVP, Chief Marketing OfficerOct 30Option Exercise75.892,287173,56013,403Nov 03 04:48 PM
MIZELL STEVENEVP, Chief HR OfficerOct 30Option Exercise75.894,574347,1217,624Nov 03 04:44 PM
Clyburn FrankEVP, Chief Commercial OfficerOct 30Option Exercise75.892,287173,56083,656Nov 03 04:55 PM
Davis Robert MEVP, Global Svcs & CFOOct 05Option Exercise0.00251,2730422,329Oct 06 04:52 PM
Davis Robert MEVP, Global Svcs & CFOOct 05Sale81.03251,27320,360,325171,056Oct 06 04:52 PM
Chattopadhyay SanatExe V-P & Pres. MMDAug 13Sale83.0110,380861,67667,373Aug 17 06:36 PM
Clyburn FrankEVP, Chief Commercial OfficerAug 05Option Exercise0.0018,876099,639Aug 06 04:53 PM
Clyburn FrankEVP, Chief Commercial OfficerAug 05Sale81.5518,8761,539,27480,763Aug 06 04:53 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJul 17Option Exercise0.0018,111062,862Jul 20 04:53 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJul 17Sale80.0036,2852,902,97626,577Jul 20 04:53 PM
BRUN LESLIE ADirectorMay 07Option Exercise0.005,00006,948May 07 04:48 PM
WEEKS WENDELL PDirectorMay 07Option Exercise0.005,00005,100May 07 04:50 PM
WEEKS WENDELL PDirectorMay 07Sale76.025,000380,104100May 07 04:50 PM
BRUN LESLIE ADirectorMay 07Sale75.465,000377,3001,948May 07 04:48 PM
Nally MichaelEVP, Chief Marketing OfficerMay 05Option Exercise76.862,345180,23712,054May 06 05:14 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 05Option Exercise76.863,283252,33129,401May 06 05:15 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 05Option Exercise76.861,29099,1497,304May 06 05:16 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 05Option Exercise76.863,752288,37982,611May 06 05:17 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 04Option Exercise77.671,904147,88479,797May 06 05:17 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 04Option Exercise77.6769253,7486,252May 06 05:16 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise77.671,21294,13626,715May 06 05:15 PM
Zachary JenniferEVP, General CounselMay 04Option Exercise77.675,772448,3119,489May 06 05:13 PM
Nally MichaelEVP, Chief Marketing OfficerMay 04Option Exercise77.671,298100,81610,274May 06 05:14 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 03Option Exercise77.6787567,96125,934May 05 04:48 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 03Option Exercise77.671,541119,6896,089May 05 04:42 PM